Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Chinese Patent Office
Fish and Richardson
Cerilliant
McKinsey
US Department of Justice
McKesson
Queensland Health

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090463

« Back to Dashboard

NDA 090463 describes PERINDOPRIL ERBUMINE, which is a drug marketed by Ani Pharms Inc, Apotex, Aurobindo Pharma, Lupin Ltd, and West-ward Pharms Int, and is included in five NDAs. It is available from three suppliers. Additional details are available on the PERINDOPRIL ERBUMINE profile page.

The generic ingredient in PERINDOPRIL ERBUMINE is perindopril erbumine. There are fourteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the perindopril erbumine profile page.
Summary for 090463
Tradename:PERINDOPRIL ERBUMINE
Applicant:Apotex
Ingredient:perindopril erbumine
Patents:0
Therapeutic Class:Cardiovascular Agents
Medical Subject Heading (MeSH) Categories for 090463

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength2MG
Approval Date:Aug 30, 2010TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength4MG
Approval Date:Aug 30, 2010TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength8MG
Approval Date:Aug 30, 2010TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Mallinckrodt
Chubb
Daiichi Sankyo
Covington
McKesson
Express Scripts
Boehringer Ingelheim
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.